Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




HPV Positive Throat Cancer Patients Need Less Neck Surgery

By HospiMedica International staff writers
Posted on 29 Sep 2014
Patients with oropharyngeal cancer (OPC) resulting from human papillomavirus (HPV) show significantly higher rates of complete response on a post-radiation neck dissection, according to a new study.

Researchers at the Fox Chase Cancer Center (FCCC; Philadelphia, PA, USA) reviewed the medical records of 396 patients whose oropharyngeal tumors had spread to at least one lymph node. More...
Within 180 days of completing radiation therapy, 146 of the patients underwent neck surgery to remove persistent lumps in their neck; of these, 99 patients had records that indicated whether or not their tumors had likely been triggered by HPV.

The researchers found that patients with HPV often responded better to treatment for OPC than those without. The same trend suggested that those that tested positive for HPV—measured by the presence of a protein called p16—were less likely to have a recurrence of their cancers, regardless of whether or not the tumors had completely disappeared following treatment. Patients’ HPV status was also the strongest predictor of whether or not they were alive at the end of the study. The study was presented at the American Society for Radiation Oncology (ASRO) annual meeting, held during September 2014 in Chicago (IL, USA).

“Among the patients who underwent neck surgery, any lingering bumps were more likely to be benign if patients were infected with HPV,” said lead author and study presenter Thomas Galloway, MD, director of clinical research at FCCC. “For patients that achieve a complete response, neck surgery is probably unnecessary. The bump might have become a permanent scar, or in some cases, it would have eventually disappeared.”

HPV oral infection precedes the development of the related OPC. Slight injury to the mucous membrane serves as an entry gate for HPV, which thus works into the basal layer of the epithelium. An earlier prospective study found that increased HPV+ OPC risk was observed more than 15 years after HPV exposure, pointing to a slow development of the disease, much like cervical cancer.

Related Links:

Fox Chase Cancer Center 



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: Lead study author Ramy Ghanim (left) and co-author Joy Jackson test an small implantable device alongside Assistant Professor Alex Abramson. In a new Science paper, they describe a networking system that connects therapeutic implants and wearable devices by using the body’s natural conductivity to send tiny signals. (Photo courtest of Georgia Tech)

Bioelectronic Network Enables Devices to Communicate Through Body Tissue and Coordinate Therapy

Wearable sensors and implanted therapeutic devices can be difficult to coordinate when signals must pass through the body. Conventional wireless signals do not travel well through tissue, while the antennas... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.